Has Ghana's Rotavirus Vaccine Switch Met Programmatic Expectations? An Analysis of National Surveillance Data; 2018–2022
Ghana's rotavirus vaccine switch yielded expected programmatic benefits without any untoward effects. The trends of vaccine uptake and reduction in diarrhea morbidity were sustained. These experiences and lessons from the rotavirus vaccine switch are vital for potential switches for other vaccines in the current immunization schedule to mitigate the annual vaccine expenditure.
Authors
- Patrick Kuma‐Aboagye
- Kwame Amponsa-Achiano (ORCID: https://orcid.org/0000-0001-8145-970X)
- Naziru Tanko Mohammed (ORCID: https://orcid.org/0009-0000-0278-9605)
- Michael Rockson Adjei (ORCID: https://orcid.org/0000-0002-8813-1800)
- Franklin Asiedu‐Bekoe (ORCID: https://orcid.org/0000-0002-0691-5020)
- Rafiq Okine (ORCID: https://orcid.org/0000-0002-9837-9172)
- Sally-Ann Ohene (ORCID: https://orcid.org/0000-0002-7511-5270)
- Martin P. Grobusch (ORCID: https://orcid.org/0000-0002-0046-1099)
- George Bonsu
- Justice Ofori Amoah
- Jason M. Mwenda
Institutions
- World Health Organization - Pakistan (PK)
- University of Cape Town (ZA)
- Centre de Recherche Médicales de Lambaréné (GA)
- Program for Appropriate Technology in Health (IN)
- World Health Organization (CH)
- World Health Organization Regional Office for Africa (CG)
- Amsterdam University Medical Centers (NL)
- Ghana Health Service (GH)
- University of Tübingen (DE)
- University of Amsterdam (NL)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1093/ofid/ofae539
- Primary Topic
- Viral gastroenteritis research and epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00